Acetamide,N,N'-1,5-pentanediylbis[2-iodo-

Suppliers

Names

[ CAS No. ]:
64058-91-9

[ Name ]:
Acetamide,N,N'-1,5-pentanediylbis[2-iodo-

[Synonym ]:
S 126
ACETAMIDE,N,N'-PENTAMETHYLENEBIS(IODO
Acetamide,N'-1,5-pentanediylbis[2-iodo
N,N'-Pentamethylene-bis(iodoacetamide)

Chemical & Physical Properties

[ Density]:
1.932g/cm3

[ Boiling Point ]:
561.6ºC at 760mmHg

[ Molecular Formula ]:
C9H16I2N2O2

[ Molecular Weight ]:
438.04400

[ Flash Point ]:
293.5ºC

[ Exact Mass ]:
437.93000

[ PSA ]:
58.20000

[ LogP ]:
2.04090

[ Index of Refraction ]:
1.594

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AC7050000
CHEMICAL NAME :
Acetamide, N,N'-pentamethylenebis(iodo-
CAS REGISTRY NUMBER :
64058-91-9
LAST UPDATED :
199201
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C9-H16-I2-N2-O2
MOLECULAR WEIGHT :
438.07
WISWESSER LINE NOTATION :
I1VM5MV1I

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
11 mg/kg
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain Nutritional and Gross Metabolic - other changes
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. Volume(issue)/page/year: 31,297,1963
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
1600 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. Volume(issue)/page/year: 31,297,1963

Related Compounds

  • Acetamide,N,N'-1,5-pentanediylbis[2-chloro-
  • Acetamide,N,N'-1,5-pentanediylbis-
  • N,N'-(Naphthalene-1,5-diyl)bis[2-(aminooxy)acetamide]
  • Acetamide, N,N'-1,5-naphthalenediylbis- (en)
  • Acetamide, N,N'-(1,2-ethynediyldi-4,1-phenylene)bis- (en)
  • Acetamide,N,N'-1,2-ethanediylbis[2-chloro-
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • 5-chloro-3-(3,5-dimethylphenyl)sulfonyl-4-fluoro-N-(morpholinomethyl)-1H-indole-2-carboxamide
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide